The fund targets early‑stage African startups and has a sizable seed‑stage allocation, aligning with the founder's pre‑seed/seed financing needs. While the focus is broad, the health‑tech angle matches the e‑pharmacy platform, though the fund is not a grant or incubator, so the fit is moderate.